Lv1
40 积分 2022-08-22 加入
Variable Response to ALK Inhibitors in NSCLC with a Novel MYT1L-ALK Fusion
3个月前
已完结
Selpercatinib Controls Central Nervous System Disease in Patients With NSCLC With RET Fusion
3个月前
已完结
Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Mutant NSCLC
3个月前
已完结
Thymic Carcinoma With Malignant Effusion—a Rare Cytologic and Radiologic Mimicker of Metastatic NSCLC
3个月前
已完结
Alectinib in resected ALK-positive non-small-cell lung cancer
3个月前
已完结
皖公网安备34019202002308
